
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) has demonstrated solid performance, particularly in its Asian markets and wealth management divisions, although recent government tax regulations in China pose challenges. Experts generally view MFC as a reliable investment with a decent dividend yield, but caution is advised due to signs of overvaluation in the Canadian financial sector. Comparatively, it is considered attractive relative to banks such as TD, although some analysts express concerns about recent earnings drops and recommend waiting for market pullbacks to buy in. The consensus highlights MFC's solid fundamentals despite a slightly overbought situation, showcasing both short-term challenges and long-term growth potential.
From a seasonal perspective, this tends to peak at around May, but the best month by far is February, which has an 81% frequency of success over the past 16 years. In April and May, the frequency falls to 50%. This stock had a huge decline today of 5.27%, breaking below its major moving averages. It looks like it is on track to test the February low of $15.32. There could be further downside. There is nothing to suggest that the selling is over.
You have seen Canadian banks go up, but Canadian insurers got left behind. Insurance companies try to fund liabilities through their assets, and in a low interest rate environment, where you have equity market volatility, it becomes much more difficult to do that. Ideally you want interest rates and equities to go up. He likes the insurance companies here, but thinks you are going to be restrained by the direction of interest rates.
It has been a tough place to make money. They did a good job of getting into Asia, who are getting older and wealthier quickly. There are lots of good things going on. He never bought it because he finds more attractive places to be in the space. It has been in the penalty box since they cut their dividend. There are better places for capital.
The last earnings report was quite a disappointment. He has been neutral to negative on this company for some time. They keep missing their objectives and did some write-downs. One concern is that a lot of their growth has come out of Asia, particularly China, and the situation there is a bit murky. Prefers Sun Life (SLF-T) or the banks. (See Top Picks.)
This is a tough call. If you are bent on owning an insurance company, this is probably one of the better ones. Have good assets, a good insurance book and good exposure to equity markets. They lowered their risk profile from 2008. Also, relatively cheap. The bigger concern is whether you should own an insurance company or not. They are heavily leveraged to the interest rate cycle, and every year we have said interest rates have got to go up, but instead they have come down. It’s a slow growth economy, so there is no need for higher interest rates. You are better off with Canadian banks which are cheaper.
This has pulled back, a lot like US banks. Lifecos are all exposed to interest rates, and get squeezed when rates don’t go up. This has a lot of growth in Asia that is kind of non-interest rate exposed. They also have John Hancock in the US. He is showing 9X earnings and a discount to Book forward, which is as cheap as these things get. It will go back to $21-$22. Dividend yield of 4.03%.